Provided by Tiger Trade Technology Pte. Ltd.

AIxCrypto Holdings, Inc.

0.8212
+0.05126.65%
Post-market: 0.8048-0.0164-2.00%19:34 EDT
Volume:38.17K
Turnover:29.58K
Market Cap:16.62M
PE:-0.14
High:0.8323
Open:0.7500
Low:0.7400
Close:0.7700
52wk High:8.81
52wk Low:0.6800
Shares:20.23M
Float Shares:20.11M
Volume Ratio:0.73
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.7844
EPS(LYR):-8.1106
ROE:-186.25%
ROA:-49.86%
PB:1.01
PE(LYR):-0.10

Loading ...

Company Profile

Company Name:
AIxCrypto Holdings, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
10
Office Location:
5857 Owens Avenue,Suite 300,Carlsbad,California,United States
Zip Code:
92008
Fax:
- -
Introduction:
Qualigen Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Directors

Name
Position
Chad Chen
Independent Director
Chen Shi
Independent Director
Kevin Chen
Independent Director

Shareholders

Name
Position
Jiawei Wang
Chief Executive Officer
Jie Sheng
Chief Financial Officer and President